An easily-applied and cheap hemostatic (an anti-bleeding agent) powder used at the end of robotic prostate cancer surgery may dramatically improve patient outcomes and represent a shortcut for less-experienced surgeons to substantially improve their results.
Wednesday 1 September, 2021 A study published today in the Journal of Urology (J Urol 2021; 206: e264-265 https://www.auajournals.org/doi/10.1097/JU.0000000000001996.04) and...
